IN2013MU03565A - - Google Patents
Download PDFInfo
- Publication number
- IN2013MU03565A IN2013MU03565A IN3565MU2013A IN2013MU03565A IN 2013MU03565 A IN2013MU03565 A IN 2013MU03565A IN 3565MU2013 A IN3565MU2013 A IN 3565MU2013A IN 2013MU03565 A IN2013MU03565 A IN 2013MU03565A
- Authority
- IN
- India
- Prior art keywords
- processes
- preparation
- lorcaserin
- relates
- solvates
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
Abstract
ABSTRACT “PROCESSES FOR THE PREPARATION OF LORCASERIN” The present invention relates to stable crystalline Form I of lorcaserin hydrochloride of Formula (IA) and processes for its preparation. The invention also relates to processes for the preparation of lorcaserin and pharmaceutically acceptable salts, solvates and hydrates thereof. (IA)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15/035,876 US9714225B2 (en) | 2013-11-13 | 2014-11-13 | Processes for the preparation of lorcaserin |
PCT/IN2014/000718 WO2015102017A1 (en) | 2013-11-13 | 2014-11-13 | Processes for the preparation of lorcaserin |
IN3565MU2013 IN2013MU03565A (en) | 2013-11-13 | 2014-11-13 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN3565MU2013 IN2013MU03565A (en) | 2013-11-13 | 2014-11-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2013MU03565A true IN2013MU03565A (en) | 2015-07-24 |
Family
ID=52785144
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN3565MU2013 IN2013MU03565A (en) | 2013-11-13 | 2014-11-13 |
Country Status (3)
Country | Link |
---|---|
US (1) | US9714225B2 (en) |
IN (1) | IN2013MU03565A (en) |
WO (1) | WO2015102017A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105924396B (en) * | 2015-12-18 | 2018-08-21 | 重庆两江药物研发中心有限公司 | A kind of preparation method of green card color woods |
CN106389377A (en) * | 2016-08-31 | 2017-02-15 | 安徽省润生医药股份有限公司 | Lorcaserin hydrochloride capsule and preparation process thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT1838677E (en) * | 2004-12-21 | 2009-11-16 | Arena Pharm Inc | Crystalline forms of (r)-8-chloro-1-methyl- 2,3,4,5-tetrahydro-1h-3-benzazepine hydrochloride |
US8168782B2 (en) * | 2006-04-03 | 2012-05-01 | Arena Pharmaceuticals, Inc. | Processes for the preparation of 8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine and intermediates related thereto |
CN101547892B (en) * | 2006-12-05 | 2014-08-20 | 艾尼纳制药公司 | Processes for preparing (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine and intermediates thereof |
US8399011B1 (en) * | 2012-08-10 | 2013-03-19 | Magnifica Inc. | Oral particle compositions containing a core and an acid-soluble coat |
-
2014
- 2014-11-13 IN IN3565MU2013 patent/IN2013MU03565A/en unknown
- 2014-11-13 US US15/035,876 patent/US9714225B2/en not_active Expired - Fee Related
- 2014-11-13 WO PCT/IN2014/000718 patent/WO2015102017A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2015102017A1 (en) | 2015-07-09 |
US9714225B2 (en) | 2017-07-25 |
US20160280658A1 (en) | 2016-09-29 |
WO2015102017A8 (en) | 2015-08-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12017500408A1 (en) | Heteroaryl compunds as btk inhibitors and uses thereof | |
PH12016500467B1 (en) | Aminoheteroarlyl benzamides as kinase inhibitors | |
PH12015501996B1 (en) | Heterocyclic compounds and uses thereof | |
PH12015502031B1 (en) | Tetrahydropyrrolothiazine compounds | |
MX2016011992A (en) | Piperidine-dione derivatives. | |
PH12015501363B1 (en) | Chloro-pyrazine carboxamide derivatives with epithelial sodium channel blocking activity | |
MY197698A (en) | Oxysterols and methods of use thereof | |
MY176803A (en) | Polymorph of syk inhibitors | |
PH12015501588A1 (en) | Compounds and methods for treating bacterial infections | |
PH12015502118A1 (en) | Pyridin-4-yl derivatives | |
JO3318B1 (en) | Bace inhibitors | |
IN2013MU03862A (en) | ||
AU2015292632B2 (en) | Aldosterone synthase inhibitors | |
IN2013MU03565A (en) | ||
IN2013MU04056A (en) | ||
PH12016500809B1 (en) | Glucopyranosyl - substituted indole-urea derivatives and their use as sglt inhibitors | |
IN2013CH04314A (en) | ||
IN2013MU03422A (en) | ||
IN2013MU03308A (en) | ||
IN2013MU03309A (en) | ||
IN2013MU02010A (en) | ||
IN2013MU01226A (en) | ||
MX2017005669A (en) | Benzylhydroxyde derivatives, preparation thereof and therapeutic use thereof. | |
IN2013CH04981A (en) | ||
IN2013MU01160A (en) |